FIRMQUARRYResearch workspace
| Date | Contract | Company | Buyer / agency | Value |
|---|
| Dec 1, 2026 | MCKESSON REGULAR MEDICATION DECEMBER 2026 FISCAL YEAR 2027 RP#: 72-FY27 | MCKESSON CORPORATION | Not reported | $469.8K |
| Nov 1, 2026 | B1 MCKESSON NON-CONTRACT FY27 OCT B1 MCKESSON NON-CONTRACT ACCT 010457 - (MULTIPLE INVOICES FOR MEDICATION SHIPMENTS FOR USE IN FY27 1-30 NOV) | MCKESSON CORPORATION | Not reported | $19.9K |
| Nov 1, 2026 | FY27 NOV 26 B7 MCKESSON PRIME 13F | MCKESSON CORPORATION | Not reported | $120K |
| Nov 1, 2026 | B1 MCKESSON NON-CONTROLLED AND CONTROLLED SUBSTANCES | MCKESSON CORPORATION | Not reported | $634K |
| Nov 1, 2026 | PHARMACEUTICALS - NOVEMBER | MCKESSON CORPORATION | Not reported | $133.6K |
| Nov 1, 2026 | FY27 B1 MCKESSON MEDICATION NOV 26 | MCKESSON CORPORATION | Not reported | $176.2K |
| Nov 1, 2026 | AMARILLO VA PHARMACY COMPOUNDING ORDER FOR ONCOLOGY MEDICATIONS | OPTUM INFUSION SERVICES 308, LLC | Not reported | $100K |
| Nov 1, 2026 | MCKESSON REGULAR MEDICATION NOVEMBER 2026 FISCAL YEAR 2027 RP#: 68-27 | MCKESSON CORPORATION | Not reported | $115.2K |
| Oct 26, 2026 | ILLUCCIX | TELIX PHARMACEUTICALS US INC | Not reported | $168K |
| Oct 20, 2026 | PAPZIMEOS IMMUNOTHERAPY | ASD SPECIALTY HEALTHCARE, LLC | Not reported | $351.4K |
| Oct 20, 2026 | NARCOTIC MEDICATIONS FOR OUD/MAT | MCKESSON CORPORATION | Not reported | $663.6 |
| Oct 20, 2026 | FY 2027 ESTIMATE DM GLUCOMETER STRIPS AND SOLUTION FROM MCKESSON | MCKESSON CORPORATION | Not reported | $1.5K |
| Oct 20, 2026 | RP# MK27-01 MCKESSON REGULAR MEDICATIONS REGULAR MEDICATION FILL OR KILL CONTROLLED SUBSTANCES FOR PENAL INSTITUTION DELIVER TO PHARMACIST ONLY | MCKESSON CORPORATION | Not reported | $8K |
| Oct 19, 2026 | NIGHT STOCK INJECTABLES FY27 | MCKESSON CORPORATION | Not reported | $20K |
| Oct 1, 2026 | CONTROLLED MEDICATION OCT 1,2026 - SEP 30, 2027 | MCKESSON CORPORATION | Not reported | $300 |
| Oct 1, 2026 | MCKESSON OPEN MARKET Q1 MEDICATION FY27 MEDICATION FOR INMATE POPULATION CR - HR 6500 EXP 12.11.2026 | MCKESSON CORPORATION | Not reported | $2K |
| Oct 1, 2026 | MCKESSON REG MEDICATION FY27Q1 CR - HR 6500 EXP 12.11.2026 MEDICATION FOR INMATE POPULATION 10/01/2026 - 12/11/2026 | MCKESSON CORPORATION | Not reported | $80K |
| Oct 1, 2026 | FY 27 MCKESSON OPEN MARKET DELIVERY ORDER AGAINST 36W79720D0001, AGAINST CONTROLLED SUBSTANCES FOR FCI EL RENO *PRIOR KNOWLEDGE OF THESE SERVICES ARE APPROVED BY THE CONTRACTING O | MCKESSON CORPORATION | Not reported | $15K |
| Oct 1, 2026 | FY27 OCT 26 B7 FSA MCKESSON MAT MEDICATION | MCKESSON CORPORATION | Not reported | $20K |
| Oct 1, 2026 | MCKESSON PRIME | MCKESSON CORPORATION | Not reported | $180K |
Top agencies
- 01General Services Administration1 awards$58.2M
- 02Department of Defense125 awards$3.7M
- 03Department of Health and Human Services29 awards$34.2M
- 04Department of Justice71 awards$3M
- 05Department of Veterans Affairs15 awards$1.6M
- 06Department of Commerce1 awards-$318.7
Top recipient locations
- 01LUZERNE, PA1 awards$997.7
- 02MONTGOMERY, MD1 awards$90.2K
- 03SANTA CLARA, CA4 awards$846.5K
- 04MONROE, PA1 awards$65.9K
- 05CHATHAM, NC1 awards$64.7K
- 06HUNTERDON, NJ7 awards$587.2K
- 07DESOTO, MS1 awards$58.2M
- 08WASHINGTON, TX1 awards$54.4
- 09DALLAS, TX72 awards$5.2M
- 10EL PASO, CO1 awards$48.8K
Top performance locations
- 01LUZERNE, PA1 awards$997.7
- 02PHILADELPHIA, PA1 awards$83K
- 03SANTA CLARA, CA3 awards$821.8K
- 04LEBANON, PA1 awards$72.2K
- 05MARLBORO, SC1 awards$663.6
- 06MONROE, PA1 awards$65.9K
- 07UINTAH, UT1 awards$650K
- 08BELL, TX1 awards$64.7K
- 09EL PASO, TX1 awards$59.1K
- 10CLARK, NV1 awards$58.2M
Annual activity
$184.4K2008
$285.4K2010
$974.5K2013
$184.4K2014
$19.5K2016
$756.7K2017
$152.4K2018
$1.4M2019
$866.1K2020
$1.8M2021
$23M2022
$65.1M2023
$855.5K2024
$5.1M2026